使用SARS-CoV-2尖峰和SARS-CoV核囊的联合免疫保护K18-hACE2小鼠,但增加了肺病理

Jaekwan Kim1, Alla Kachko1, Prabhuanand Selvaraj1

  • 1Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

NPJ vaccines
|February 13, 2025
PubMed
概括

结合SARS-CoV-2尖峰和核囊蛋白的下一代疫苗提供了保护. 然而,使用一种变异性核囊抗原可能会增加肺病理,尽管病毒控制.